We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
THC Farmaceuticals Inc (PK) | USOTC:CBDG | OTCMarkets | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.043 | 0.0166 | 0.0493 | 0.00 | 14:30:28 |
FRANKFURT--The following is a summary of analysts' forecasts for UBS AG (UBS) third-quarter results, based on a poll of five analysts conducted by Dow Jones Newswires (figures in million francs, EPS, dividend and target price in franc, according to IFRS). Earnings figures are scheduled to be released October 28.
=== Net Total Total attrib. 3rd Quarter revenues oper. exp. EBT profit EPS AVERAGE 7,016 6,172 764 787 0.21 Prev. Year 6,261 5,906 356 577 0.15 +/- in % +12 +4.5 +114 +36 +38 MEDIAN 6,935 6,307 825 962 0.26 Maximum 7,346 6,598 1,076 985 0.26 Minimum 6,929 5,477 305 237 0.06 Amount 5 4 5 4 4 Baader-Helvea 7,346 6,480 866 -- -- Barclays 6,935 6,598 305 237 0.06 Credit Suisse 6,939 5,477 1,076 968 0.26 Deutsche Bank 6,931 -- 825 985 0.26 Kepler Cheuvreux 6,929 6,134 746 956 0.25 Target price Rating DPS 2014 AVERAGE 17.60 positive 1 AVERAGE 0.64 Prev. Quarter 20.02 neutral 4 Prev. Year 0.25 +/- in % -12 negative 0 +/- in % +155 MEDIAN 17.00 MEDIAN 0.60 Maximum 20.00 Maximum 0.85 Minimum 16.50 Minimum 0.50 Amount 5 Amount 4 Baader-Helvea 17.50 Hold -- Credit Suisse 16.50 Neutral 0.70 Deutsche Bank 20.00 Buy 0.50 Independent Research 17.00 Hold 0.50 Kepler Cheuvreux 17.00 Hold 0.85 ===
Year-earlier figures are as reported by the company.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
1 Year THC Farmaceuticals (PK) Chart |
1 Month THC Farmaceuticals (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions